Dermatology Times Newsletter

To view this email as a web page, click here.

Catch up on highlights from Fall Clinical Dermatology Conference presentations you may have missed. Visit our conference coverage page.

JAK inhibitors will change dermatologic therapy

JAK inhibitors have shown efficacy across several conditions due to the number and role of cytokines in the pathogenesis of these conditions, says Brett King, M.D.

Pruritus therapies: What you’ve been itching to know

The shift from antihistamines to newer drugs for treating pruritus is rapidly accelerating. Gil Yosipovitch, M.D. shares the treatments you should know.

Genetic expression profiling for squamous cell carcinoma

For many years, genetic expression profiling has helped physicians predict which patients are at the highest risk of having their melanoma metastasize. Now, this same approach could aid in treating squamous cell carcinoma of the skin.

How to treat adult female acne

Hilary Baldwin, M.D., discusses the nuances of adult female acne and its treatments.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.